Summary — SB 2795: "Pharmacy Practice Act; extend repealer on and make various changes in."
Status: Died On Calendar
Introduced: March 14, 2025
Subject: Public Health and Welfare
Purpose / Intent
SB 2795 is titled to extend the repealer (sunset) of the state's Pharmacy Practice Act and to make various amendments to that statute. In general, bills of this type seek to (1) continue the statutory framework that governs the licensing, practice, and regulation of pharmacists and pharmacies by postponing or renewing a scheduled expiration date, and (2) update regulatory provisions to reflect practice changes, technology, or policy priorities.
Note: The bill text (full version content) was not provided. The summary below outlines the bill’s stated aim and typical categories of change such legislation usually addresses. For exact language and specific provisions, consult the bill text on the state legislative website.
Key provisions likely covered (based on bill title and common practice)
Because the detailed bill content is not included here, the following are the types of provisions commonly included when a Pharmacy Practice Act repealer is extended and the Act is amended:
- Extend the Act’s repealer/sunset date to keep the Pharmacy Practice Act in effect for an additional legislative period.
- Clarify or update definitions (e.g., “pharmacist,” “pharmacy technician,” “telepharmacy,” “collaborative practice”).
- Modify scope-of-practice rules (for example, authority for pharmacists to administer vaccines, provide point-of-care testing, furnish certain medications, or engage in collaborative practice agreements).
- Update licensure, renewal, and continuing education requirements for pharmacists and technicians.
- Address pharmacy technician roles and delegation/supervision standards.
- Establish or expand telepharmacy and remote verification provisions.
- Revise rules for dispensing controlled substances (including alignment with PDMP requirements and electronic prescribing).
- Update compounding, sterile compounding, and quality-control standards.
- Change disciplinary procedures, penalties, or enforcement authority for the state board of pharmacy.
- Adjust fees or funding mechanisms related to licensure and regulatory oversight.
Who would be affected
- Licensed pharmacists and pharmacy technicians (practice authority, duties, education/CE requirements).
- Community, hospital, and long-term care pharmacies (operations, staffing, telepharmacy).
- Patients/consumers (access to services like immunizations, point-of-care testing, pharmacist-provided care).
- State board of pharmacy or regulatory agency (continued authority, enforcement responsibilities).
- Employers and health systems (compliance costs, workflow changes).
- Payers/insurers if the bill affects billing/coverage for pharmacist services.
Procedural / timeline notes
Provided legislative actions:
- Filed / Received by Secretary of the Senate: March 14, 2025
- Read first time: April 3, 2025
- Referred to Jurisprudence: April 3, 2025
- Referred to Public Health and Welfare: January 20, 2025 (record shows earlier referral as well)
- Title Suff Do Pass Comm Sub: February 4, 2025
- Final status listed as: Died On Calendar (date recorded: February 13, 2025)
(There are inconsistencies in the dates provided in the record above. The bill’s final status is recorded as “Died On Calendar,” meaning it did not advance to final passage during the legislative session.)
Potential impact
- If enacted as typical for such legislation, extending the repealer would preserve regulatory continuity for pharmacy practice and avoid a lapse in statutory authority.
- Amendments could expand pharmacist scope-of-practice and increase patient access to pharmacist-delivered services, while also imposing new compliance or training requirements on licensees.
- Changes may affect operational costs for pharmacies (staffing, technology for telepharmacy or electronic prescribing) and could shift some health care delivery toward pharmacists.
Recommendation: For authoritative details and to assess concrete impacts, review the bill’s full text and any committee analyses or fiscal notes available from the legislature.
